Healthpeak Properties (NYSE:DOC) Downgraded to Sell Rating by StockNews.com

StockNews.com downgraded shares of Healthpeak Properties (NYSE:DOC) from a hold rating to a sell rating in a research report sent to investors on Thursday morning.

DOC has been the topic of a number of other research reports. Argus reiterated a “buy” rating and set a $25.00 price objective on shares of Healthpeak Properties in a research note on Tuesday, April 29th. Robert W. Baird dropped their price objective on Healthpeak Properties from $24.00 to $22.00 and set an “outperform” rating on the stock in a research note on Tuesday, April 29th. Scotiabank decreased their target price on Healthpeak Properties from $24.00 to $23.00 and set a “sector outperform” rating for the company in a research note on Friday, February 28th. Evercore ISI dropped their price target on shares of Healthpeak Properties from $23.00 to $21.00 and set an “outperform” rating on the stock in a research report on Monday, April 28th. Finally, Wedbush cut their price target on shares of Healthpeak Properties from $24.00 to $22.00 and set an “outperform” rating for the company in a report on Monday, April 28th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and nine have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $23.42.

Healthpeak Properties Trading Up 0.1 %

NYSE:DOC opened at $17.79 on Thursday. The firm has a market capitalization of $12.36 billion, a P/E ratio of 50.83, a P/E/G ratio of 2.17 and a beta of 1.02. The business has a 50 day simple moving average of $19.37 and a 200 day simple moving average of $20.42. The company has a debt-to-equity ratio of 0.96, a current ratio of 1.35 and a quick ratio of 1.35. Healthpeak Properties has a 12-month low of $17.33 and a 12-month high of $23.26.

Healthpeak Properties (NYSE:DOC) last announced its quarterly earnings results on Thursday, April 24th. The real estate investment trust reported $0.46 EPS for the quarter, meeting the consensus estimate of $0.46. Healthpeak Properties had a net margin of 9.00% and a return on equity of 2.61%. The company had revenue of $702.89 million for the quarter, compared to analyst estimates of $690.76 million. During the same quarter last year, the business earned $0.45 earnings per share. Healthpeak Properties’s revenue was up 15.9% compared to the same quarter last year. Equities research analysts predict that Healthpeak Properties will post 1.86 EPS for the current year.

Healthpeak Properties Dividend Announcement

The company also recently announced a dividend, which was paid on Wednesday, April 30th. Shareholders of record on Friday, April 18th were issued a $0.1017 dividend. This represents a dividend yield of 6.5%. The ex-dividend date was Thursday, April 17th. Healthpeak Properties’s payout ratio is 305.00%.

Insider Transactions at Healthpeak Properties

In other Healthpeak Properties news, Director John T. Thomas acquired 4,200 shares of Healthpeak Properties stock in a transaction that occurred on Monday, April 28th. The stock was purchased at an average cost of $17.84 per share, with a total value of $74,928.00. Following the purchase, the director now owns 813,566 shares in the company, valued at approximately $14,514,017.44. The trade was a 0.52 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Scott M. Brinker acquired 11,337 shares of the firm’s stock in a transaction on Monday, April 28th. The shares were acquired at an average price of $17.68 per share, with a total value of $200,438.16. Following the completion of the transaction, the chief executive officer now directly owns 201,863 shares in the company, valued at approximately $3,568,937.84. This trade represents a 5.95 % increase in their position. The disclosure for this purchase can be found here. 0.23% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in the stock. JPMorgan Chase & Co. boosted its stake in shares of Healthpeak Properties by 23.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 21,561,640 shares of the real estate investment trust’s stock valued at $493,115,000 after buying an additional 4,056,931 shares during the period. Vert Asset Management LLC raised its holdings in shares of Healthpeak Properties by 11.1% during the fourth quarter. Vert Asset Management LLC now owns 304,219 shares of the real estate investment trust’s stock worth $6,167,000 after acquiring an additional 30,461 shares in the last quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund boosted its position in Healthpeak Properties by 25.7% during the fourth quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 109,200 shares of the real estate investment trust’s stock valued at $2,213,000 after purchasing an additional 22,300 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. grew its stake in Healthpeak Properties by 16.6% in the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 110,498 shares of the real estate investment trust’s stock valued at $2,217,000 after purchasing an additional 15,753 shares in the last quarter. Finally, Franklin Resources Inc. acquired a new position in Healthpeak Properties in the 3rd quarter worth about $3,224,000. Institutional investors and hedge funds own 93.57% of the company’s stock.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.